FindTrial
Sign In

A RANDOMISED DOUBLE BLIND CONTROL STUDY TO COMPARE THE EFFICACY OF TWO DIFFERENT STRENGTH OF BUPRENOPHINE AS A SPINAL ADJUVANT WITH 0.75% ROPIVACAINE IN ADULT PATIENT UNDERGOING OPEN INGUINAL HERNIA SURGERIES.

A COMPARATIVE STUDY OF EFFICACY OF TWO DIFFERENT STRENGTH OF BUPRENORPHINE AS A SPINAL ADJUVANT TO ROPIVACAINE IN PATIENTS UNDERGOING OPEN INGUINAL HERNIA SURGERIES; A RANDOMISED DOUBLE BLIND CONTROLLED TRIAL. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060726
Enrollment
104
Registered
2023-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K400- Bilateral inguinal hernia, with obstruction, without gangrene

Interventions

Intervention1: TWO DIFFERENT STRENGTHS OF BUPRENORPHINE: To compare post operative duration of analgesia in first 24 hours using visual analogue score ( VAS) in adult patient undergoing open inguinal

Sponsors

MGIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ? American Society of Anesthesiologists Grade I and II patients. ? Age above 18 years of any gender ? Patients undergoing open Inguinal hernia Surgeries. ? Height is more than 4 feet.

Exclusion criteria

Exclusion criteria: ? American Society of Anesthesiologists Grade III and IV patients. ? Patients with known contraindications for spinal anaesthesia: bleeding disorders, local infection. ? Patients with hemodynamic instability. ? Patient with allergy to or history of hypersensitivity to local anaesthetic. ? Emergency surgeries. ? Patient’s refusal.

Design outcomes

Primary

MeasureTime frame
POSTOPERATIVE ANALGESIATimepoint: 15MINS,1 HR,3HRS—

Secondary

MeasureTime frame
INTRAOP HEMODYNAMIC PARAMETRES AND TIME FOR SENSORY AND MOTOR BLOCKTimepoint: 5MINS,15MINS,30 MINS,45 MINS—

Countries

India

Contacts

Public ContactTanu Choudhary

MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES

dhirajbhandari@mgims.ac.in9970195086

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026